Trial Profile
Study of the effect of early bolus dose of tirofiban in emergency department on early TIMI flow 3 of the patients with myocardial infarction undergoing primary PCI.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2018
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Therapeutic Use
- 11 Apr 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials.
- 08 Oct 2011 New trial record